vs
Side-by-side financial comparison of Pediatrix Medical Group, Inc. (MD) and INTERFACE INC (TILE). Click either name above to swap in a different company.
Pediatrix Medical Group, Inc. is the larger business by last-quarter revenue ($493.8M vs $349.4M, roughly 1.4× INTERFACE INC). INTERFACE INC runs the higher net margin — 7.0% vs 6.8%, a 0.2% gap on every dollar of revenue. On growth, INTERFACE INC posted the faster year-over-year revenue change (4.3% vs -1.7%). Over the past eight quarters, INTERFACE INC's revenue compounded faster (9.8% CAGR vs -0.1%).
Pediatrix Medical Group, Inc. is a leading U.S. specialized medical service provider focusing on maternal-fetal care, neonatology, pediatric cardiology and other pediatric subspecialties. It partners with U.S. healthcare facilities to deliver evidence-based care to women, newborns and children.
Interface, Inc., headquartered in Atlanta, Georgia, is a global manufacturer of commercial flooring. The company sells modular carpet tiles, luxury vinyl tile, and Nora brand rubber flooring.
MD vs TILE — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $493.8M | $349.4M |
| Net Profit | $33.7M | $24.4M |
| Gross Margin | — | 38.6% |
| Operating Margin | 9.9% | 10.1% |
| Net Margin | 6.8% | 7.0% |
| Revenue YoY | -1.7% | 4.3% |
| Net Profit YoY | 10.5% | 12.1% |
| EPS (diluted) | $0.40 | $0.41 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $493.8M | $349.4M | ||
| Q3 25 | $492.9M | $364.5M | ||
| Q2 25 | $468.8M | $375.5M | ||
| Q1 25 | $458.4M | $297.4M | ||
| Q4 24 | $502.4M | $335.0M | ||
| Q3 24 | $511.2M | $344.3M | ||
| Q2 24 | $504.3M | $346.6M | ||
| Q1 24 | $495.1M | $289.7M |
| Q4 25 | $33.7M | $24.4M | ||
| Q3 25 | $71.7M | $46.1M | ||
| Q2 25 | $39.3M | $32.6M | ||
| Q1 25 | $20.7M | $13.0M | ||
| Q4 24 | $30.5M | $21.8M | ||
| Q3 24 | $19.4M | $28.4M | ||
| Q2 24 | $-153.0M | $22.6M | ||
| Q1 24 | $4.0M | $14.2M |
| Q4 25 | — | 38.6% | ||
| Q3 25 | — | 39.4% | ||
| Q2 25 | — | 39.4% | ||
| Q1 25 | — | 37.3% | ||
| Q4 24 | — | 36.5% | ||
| Q3 24 | — | 37.1% | ||
| Q2 24 | — | 35.4% | ||
| Q1 24 | — | 38.1% |
| Q4 25 | 9.9% | 10.1% | ||
| Q3 25 | 13.8% | 14.6% | ||
| Q2 25 | 12.8% | 13.9% | ||
| Q1 25 | 7.0% | 7.8% | ||
| Q4 24 | 7.8% | 8.8% | ||
| Q3 24 | 6.6% | 12.3% | ||
| Q2 24 | -31.3% | 11.0% | ||
| Q1 24 | 3.2% | 8.4% |
| Q4 25 | 6.8% | 7.0% | ||
| Q3 25 | 14.5% | 12.7% | ||
| Q2 25 | 8.4% | 8.7% | ||
| Q1 25 | 4.5% | 4.4% | ||
| Q4 24 | 6.1% | 6.5% | ||
| Q3 24 | 3.8% | 8.3% | ||
| Q2 24 | -30.3% | 6.5% | ||
| Q1 24 | 0.8% | 4.9% |
| Q4 25 | $0.40 | $0.41 | ||
| Q3 25 | $0.84 | $0.78 | ||
| Q2 25 | $0.46 | $0.55 | ||
| Q1 25 | $0.24 | $0.22 | ||
| Q4 24 | $0.37 | $0.38 | ||
| Q3 24 | $0.23 | $0.48 | ||
| Q2 24 | $-1.84 | $0.38 | ||
| Q1 24 | $0.05 | $0.24 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $375.2M | $71.3M |
| Total DebtLower is stronger | $570.5M | $181.6M |
| Stockholders' EquityBook value | $865.9M | $640.7M |
| Total Assets | $2.2B | $1.2B |
| Debt / EquityLower = less leverage | 0.66× | 0.28× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $375.2M | $71.3M | ||
| Q3 25 | $340.1M | $187.4M | ||
| Q2 25 | $224.7M | $121.7M | ||
| Q1 25 | $99.0M | $97.8M | ||
| Q4 24 | $229.9M | $99.2M | ||
| Q3 24 | $103.8M | $115.6M | ||
| Q2 24 | $19.4M | $94.2M | ||
| Q1 24 | $8.0M | $89.8M |
| Q4 25 | $570.5M | $181.6M | ||
| Q3 25 | $577.2M | $307.8M | ||
| Q2 25 | $583.9M | $304.4M | ||
| Q1 25 | $590.5M | $302.9M | ||
| Q4 24 | $597.1M | $302.8M | ||
| Q3 24 | — | $337.9M | ||
| Q2 24 | — | $387.6M | ||
| Q1 24 | — | $391.8M |
| Q4 25 | $865.9M | $640.7M | ||
| Q3 25 | $890.7M | $621.0M | ||
| Q2 25 | $833.8M | $575.0M | ||
| Q1 25 | $789.2M | $513.1M | ||
| Q4 24 | $764.9M | $489.1M | ||
| Q3 24 | $732.5M | $501.6M | ||
| Q2 24 | $706.5M | $451.2M | ||
| Q1 24 | $856.2M | $428.5M |
| Q4 25 | $2.2B | $1.2B | ||
| Q3 25 | $2.2B | $1.3B | ||
| Q2 25 | $2.1B | $1.3B | ||
| Q1 25 | $2.0B | $1.2B | ||
| Q4 24 | $2.2B | $1.2B | ||
| Q3 24 | $2.1B | $1.2B | ||
| Q2 24 | $2.0B | $1.2B | ||
| Q1 24 | $2.2B | $1.2B |
| Q4 25 | 0.66× | 0.28× | ||
| Q3 25 | 0.65× | 0.50× | ||
| Q2 25 | 0.70× | 0.53× | ||
| Q1 25 | 0.75× | 0.59× | ||
| Q4 24 | 0.78× | 0.62× | ||
| Q3 24 | — | 0.67× | ||
| Q2 24 | — | 0.86× | ||
| Q1 24 | — | 0.91× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $114.1M | $49.3M |
| Free Cash FlowOCF − Capex | — | $28.6M |
| FCF MarginFCF / Revenue | — | 8.2% |
| Capex IntensityCapex / Revenue | — | 5.9% |
| Cash ConversionOCF / Net Profit | 3.39× | 2.02× |
| TTM Free Cash FlowTrailing 4 quarters | — | $121.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $114.1M | $49.3M | ||
| Q3 25 | $137.3M | $76.7M | ||
| Q2 25 | $137.2M | $30.1M | ||
| Q1 25 | $-117.5M | $11.7M | ||
| Q4 24 | $133.0M | $38.0M | ||
| Q3 24 | $91.8M | $76.2M | ||
| Q2 24 | $107.0M | $21.5M | ||
| Q1 24 | $-125.2M | $12.6M |
| Q4 25 | — | $28.6M | ||
| Q3 25 | — | $66.1M | ||
| Q2 25 | — | $22.8M | ||
| Q1 25 | — | $4.3M | ||
| Q4 24 | — | $24.4M | ||
| Q3 24 | — | $69.7M | ||
| Q2 24 | — | $12.0M | ||
| Q1 24 | — | $8.6M |
| Q4 25 | — | 8.2% | ||
| Q3 25 | — | 18.1% | ||
| Q2 25 | — | 6.1% | ||
| Q1 25 | — | 1.4% | ||
| Q4 24 | — | 7.3% | ||
| Q3 24 | — | 20.3% | ||
| Q2 24 | — | 3.5% | ||
| Q1 24 | — | 3.0% |
| Q4 25 | — | 5.9% | ||
| Q3 25 | — | 2.9% | ||
| Q2 25 | — | 2.0% | ||
| Q1 25 | — | 2.5% | ||
| Q4 24 | — | 4.1% | ||
| Q3 24 | — | 1.9% | ||
| Q2 24 | — | 2.8% | ||
| Q1 24 | — | 1.4% |
| Q4 25 | 3.39× | 2.02× | ||
| Q3 25 | 1.91× | 1.66× | ||
| Q2 25 | 3.49× | 0.93× | ||
| Q1 25 | -5.66× | 0.90× | ||
| Q4 24 | 4.36× | 1.75× | ||
| Q3 24 | 4.72× | 2.68× | ||
| Q2 24 | — | 0.95× | ||
| Q1 24 | -31.03× | 0.89× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
MD
| Health Care Patient Service | $421.6M | 85% |
| Hospitals Contracts | $70.0M | 14% |
| Other | $2.2M | 0% |
TILE
| AMS | $205.9M | 59% |
| EAAA | $143.5M | 41% |
